Skip to main content
Erschienen in: Tumor Biology 6/2014

01.06.2014 | Research Article

Tea consumption and leukemia risk: a meta-analysis

verfasst von: Shanliang Zhong, Zhiyuan Chen, Xinnian Yu, Weixian Chen, Mengmeng Lv, Tengfei Ma, Jianhua Zhao

Erschienen in: Tumor Biology | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Epidemiologic findings concerning the association between tea consumption and leukemia risk yielded mixed results. We aimed to investigate the association by performing a meta-analysis of all available studies. One cohort studies and six case-control studies with 1,019 cases were identified using PubMed, Web of Science, and EMBASE. We computed summary relative risks (RRs) and 95 % confidence intervals (CIs) using random effect model applied to the relative risk associated with ever, moderate, or highest drinkers vs. non/lowest drinkers. Subgroup analyses were performed based on country (China and USA). Compared with non/lowest drinkers, the combined RR for ever drinkers was 0.76 (95 % CI = 0.65–0.89). In subgroup analyses, significant inverse associations were found for both China and USA studies. The summary RR was 0.57 (95 % CI = 0.41–0.78) for highest drinkers. Same results were only found in China studies. No significant associations were found for moderate drinkers in overall analysis or in subgroup analyses. There was some evidence of publication bias. In conclusion, this meta-analysis suggests a significant inverse association of high tea consumption and leukemia risk. Results should be interpreted cautiously given the potential publication bias.
Literatur
1.
Zurück zum Zitat American Cancer Society. Global cancer facts & figures 2nd edition. Atlanta: American cancer society; 2011. American Cancer Society. Global cancer facts & figures 2nd edition. Atlanta: American cancer society; 2011.
2.
Zurück zum Zitat Howlader N, Noone A, Krapcho M, Garshell J, Neyman N, Altekruse S, Kosary CL YM, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis D, Chen H, Feuer E, Cronin Ke: Seer cancer statistics review, 1975-2010, National Cancer Institute. Bethesda, md, http://seer.Cancer.Gov/csr/1975_2010/, based on November 2012 seer data submission, posted to the seer web site, 2013 Howlader N, Noone A, Krapcho M, Garshell J, Neyman N, Altekruse S, Kosary CL YM, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis D, Chen H, Feuer E, Cronin Ke: Seer cancer statistics review, 1975-2010, National Cancer Institute. Bethesda, md, http://​seer.​Cancer.​Gov/​csr/​1975_​2010/​, based on November 2012 seer data submission, posted to the seer web site, 2013
3.
4.
Zurück zum Zitat Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA J Am Med Assoc. 2006;296:1255–65.CrossRef Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA J Am Med Assoc. 2006;296:1255–65.CrossRef
5.
Zurück zum Zitat Smith DM, Dou QP. Green tea polyphenol epigallocatechin inhibits DNA replication and consequently induces leukemia cell apoptosis. Int J Mol Med. 2001;7:645–52.PubMed Smith DM, Dou QP. Green tea polyphenol epigallocatechin inhibits DNA replication and consequently induces leukemia cell apoptosis. Int J Mol Med. 2001;7:645–52.PubMed
6.
Zurück zum Zitat Ohata M, Koyama Y, Suzuki T, Hayakawa S, Saeki K, Nakamura Y, et al. Effects of tea constituents on cell cycle progression of human leukemia u937 cells. Biomed Res (Tokyo, Japan). 2005;26:1–7.CrossRef Ohata M, Koyama Y, Suzuki T, Hayakawa S, Saeki K, Nakamura Y, et al. Effects of tea constituents on cell cycle progression of human leukemia u937 cells. Biomed Res (Tokyo, Japan). 2005;26:1–7.CrossRef
7.
Zurück zum Zitat Han DH, Jeong JH, Kim JH. Anti-proliferative and apoptosis induction activity of green tea polyphenols on human promyelocytic leukemia hl-60 cells. Anticancer Res. 2009;29:1417–21.PubMed Han DH, Jeong JH, Kim JH. Anti-proliferative and apoptosis induction activity of green tea polyphenols on human promyelocytic leukemia hl-60 cells. Anticancer Res. 2009;29:1417–21.PubMed
8.
Zurück zum Zitat Iwasaki R, Ito K, Ishida T, Hamanoue M, Adachi S, Watanabe T, et al. Catechin, green tea component, causes caspase-independent necrosis-like cell death in chronic myelogenous leukemia. Cancer Sci. 2009;100:349–56.CrossRefPubMed Iwasaki R, Ito K, Ishida T, Hamanoue M, Adachi S, Watanabe T, et al. Catechin, green tea component, causes caspase-independent necrosis-like cell death in chronic myelogenous leukemia. Cancer Sci. 2009;100:349–56.CrossRefPubMed
9.
Zurück zum Zitat Wu L, Zhou YP, Zhong HJ. A case-control study on the risk factors of leukemia in mining areas of rare-earth in South Jiangxi. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2003;24:879–82.PubMed Wu L, Zhou YP, Zhong HJ. A case-control study on the risk factors of leukemia in mining areas of rare-earth in South Jiangxi. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2003;24:879–82.PubMed
10.
Zurück zum Zitat Li Y, Moysich KB, Baer MR, Weiss JR, Brasure J, Graham S, et al. Intakes of selected food groups and beverages and adult acute myeloid leukemia. Leuk Res. 2006;30:1507–15.CrossRefPubMed Li Y, Moysich KB, Baer MR, Weiss JR, Brasure J, Graham S, et al. Intakes of selected food groups and beverages and adult acute myeloid leukemia. Leuk Res. 2006;30:1507–15.CrossRefPubMed
11.
12.
Zurück zum Zitat Kuo YC, Yu CL, Liu CY, Wang SF, Pan PC, Wu MT, et al. A population-based, case-control study of green tea consumption and leukemia risk in southwestern Taiwan. Cancer Cause Control. 2009;20:57–65.CrossRef Kuo YC, Yu CL, Liu CY, Wang SF, Pan PC, Wu MT, et al. A population-based, case-control study of green tea consumption and leukemia risk in southwestern Taiwan. Cancer Cause Control. 2009;20:57–65.CrossRef
13.
Zurück zum Zitat Liu CY, Hsu YH, Wu MT, Pan PC, Ho CK, Su L, et al. Cured meat, vegetables, and bean-curd foods in relation to childhood acute leukemia risk: a population based case-control study. BMC Cancer. 2009;9:15.PubMedCentralCrossRefPubMed Liu CY, Hsu YH, Wu MT, Pan PC, Ho CK, Su L, et al. Cured meat, vegetables, and bean-curd foods in relation to childhood acute leukemia risk: a population based case-control study. BMC Cancer. 2009;9:15.PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Ma X, Park Y, Mayne ST, Wang R, Sinha R, Hollenbeck AR, et al. Diet, lifestyle, and acute myeloid leukemia in the nih-aarp cohort. Am J Epidemiol. 2010;171:312–22.PubMedCentralCrossRefPubMed Ma X, Park Y, Mayne ST, Wang R, Sinha R, Hollenbeck AR, et al. Diet, lifestyle, and acute myeloid leukemia in the nih-aarp cohort. Am J Epidemiol. 2010;171:312–22.PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Li L, Zhang M, Holman D. Population versus hospital controls for case-control studies on cancers in Chinese hospitals. BMC Med Res Methodol. 2011;11:167.PubMedCentralCrossRefPubMed Li L, Zhang M, Holman D. Population versus hospital controls for case-control studies on cancers in Chinese hospitals. BMC Med Res Methodol. 2011;11:167.PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.CrossRefPubMed Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.CrossRefPubMed
18.
Zurück zum Zitat Hedges LV, Pigott TD. The power of statistical tests in meta-analysis. Psychol Methods. 2001;6:203–17.CrossRefPubMed Hedges LV, Pigott TD. The power of statistical tests in meta-analysis. Psychol Methods. 2001;6:203–17.CrossRefPubMed
19.
Zurück zum Zitat DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.CrossRefPubMed DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.CrossRefPubMed
21.
Zurück zum Zitat Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–63.CrossRefPubMed Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–63.CrossRefPubMed
22.
Zurück zum Zitat Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992;327:248–54.CrossRefPubMed Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992;327:248–54.CrossRefPubMed
23.
Zurück zum Zitat Whitehead A. A prospectively planned cumulative meta-analysis applied to a series of concurrent clinical trials. Stat Med. 1997;16:2901–13.CrossRefPubMed Whitehead A. A prospectively planned cumulative meta-analysis applied to a series of concurrent clinical trials. Stat Med. 1997;16:2901–13.CrossRefPubMed
24.
Zurück zum Zitat Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet. 2003;361:567–71.CrossRefPubMed Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet. 2003;361:567–71.CrossRefPubMed
25.
Zurück zum Zitat Naganuma T, Kuriyama S, Kakizaki M, Sone T, Nakaya N, Ohmori-Matsuda K, et al. Green tea consumption and hematologic malignancies in Japan. Am J Epidemiol. 2009;170:730–8.CrossRefPubMed Naganuma T, Kuriyama S, Kakizaki M, Sone T, Nakaya N, Ohmori-Matsuda K, et al. Green tea consumption and hematologic malignancies in Japan. Am J Epidemiol. 2009;170:730–8.CrossRefPubMed
26.
Zurück zum Zitat Zhang XD, Zhao XY, Zhang M, Liang Y, Xu XH, D'Arcy C, et al. A case-control study on green tea consumption and the risk of adult leukemia. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2008;29:290–3.PubMed Zhang XD, Zhao XY, Zhang M, Liang Y, Xu XH, D'Arcy C, et al. A case-control study on green tea consumption and the risk of adult leukemia. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2008;29:290–3.PubMed
27.
Zurück zum Zitat Sturgeon JL, Williams M, van Servellen G. Efficacy of green tea in the prevention of cancers. Nurs Health Sci. 2009;11:436–46.CrossRefPubMed Sturgeon JL, Williams M, van Servellen G. Efficacy of green tea in the prevention of cancers. Nurs Health Sci. 2009;11:436–46.CrossRefPubMed
29.
Zurück zum Zitat Pastore RL, Fratellone P. Potential health benefits of green tea (Camellia sinensis): a narrative review. Explore (New York, NY). 2006;2:531–9.CrossRef Pastore RL, Fratellone P. Potential health benefits of green tea (Camellia sinensis): a narrative review. Explore (New York, NY). 2006;2:531–9.CrossRef
30.
Zurück zum Zitat Lecumberri E, Dupertuis YM, Miralbell R, Pichard C. Green tea polyphenol epigallocatechin-3-gallate (egcg) as adjuvant in cancer therapy. Clin Nutr. 2013;32:894–903.CrossRefPubMed Lecumberri E, Dupertuis YM, Miralbell R, Pichard C. Green tea polyphenol epigallocatechin-3-gallate (egcg) as adjuvant in cancer therapy. Clin Nutr. 2013;32:894–903.CrossRefPubMed
31.
Zurück zum Zitat Lee YK, Bone ND, Strege AK, Shanafelt TD, Jelinek DF, Kay NE. Vegf receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (egcg), in b-cell chronic lymphocytic leukemia. Blood. 2004;104:788–94.CrossRefPubMed Lee YK, Bone ND, Strege AK, Shanafelt TD, Jelinek DF, Kay NE. Vegf receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (egcg), in b-cell chronic lymphocytic leukemia. Blood. 2004;104:788–94.CrossRefPubMed
32.
Zurück zum Zitat Britschgi A, Simon HU, Tobler A, Fey MF, Tschan MP. Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acid-induced neutrophil differentiation via death-associated protein kinase 2. Br J Haematol. 2010;149:55–64.CrossRefPubMed Britschgi A, Simon HU, Tobler A, Fey MF, Tschan MP. Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acid-induced neutrophil differentiation via death-associated protein kinase 2. Br J Haematol. 2010;149:55–64.CrossRefPubMed
33.
Zurück zum Zitat Nakagawa H, Hasumi K, Woo JT, Nagai K, Wachi M. Generation of hydrogen peroxide primarily contributes to the induction of fe(ii)-dependent apoptosis in jurkat cells by (-)-epigallocatechin gallate. Carcinogenesis. 2004;25:1567–74.CrossRefPubMed Nakagawa H, Hasumi K, Woo JT, Nagai K, Wachi M. Generation of hydrogen peroxide primarily contributes to the induction of fe(ii)-dependent apoptosis in jurkat cells by (-)-epigallocatechin gallate. Carcinogenesis. 2004;25:1567–74.CrossRefPubMed
34.
Zurück zum Zitat Shim JH, Choi HS, Pugliese A, Lee SY, Chae JI, Choi BY, et al. (-)-epigallocatechin gallate regulates cd3-mediated t cell receptor signaling in leukemia through the inhibition of zap-70 kinase. J Biol Chem. 2008;283:28370–9.PubMedCentralCrossRefPubMed Shim JH, Choi HS, Pugliese A, Lee SY, Chae JI, Choi BY, et al. (-)-epigallocatechin gallate regulates cd3-mediated t cell receptor signaling in leukemia through the inhibition of zap-70 kinase. J Biol Chem. 2008;283:28370–9.PubMedCentralCrossRefPubMed
35.
Zurück zum Zitat Kawai Y, Matsui Y, Kondo H, Morinaga H, Uchida K, Miyoshi N, et al. Galloylated catechins as potent inhibitors of hypochlorous acid-induced DNA damage. Chem Res Toxicol. 2008;21:1407–14.CrossRefPubMed Kawai Y, Matsui Y, Kondo H, Morinaga H, Uchida K, Miyoshi N, et al. Galloylated catechins as potent inhibitors of hypochlorous acid-induced DNA damage. Chem Res Toxicol. 2008;21:1407–14.CrossRefPubMed
36.
Zurück zum Zitat Lopez-Lazaro M, Calderon-Montano JM, Burgos-Moron E, Austin CA. Green tea constituents (-)-epigallocatechin-3-gallate (egcg) and gallic acid induce topoisomerase i- and topoisomerase ii-DNA complexes in cells mediated by pyrogallol-induced hydrogen peroxide. Mutagenesis. 2011;26:489–98.CrossRefPubMed Lopez-Lazaro M, Calderon-Montano JM, Burgos-Moron E, Austin CA. Green tea constituents (-)-epigallocatechin-3-gallate (egcg) and gallic acid induce topoisomerase i- and topoisomerase ii-DNA complexes in cells mediated by pyrogallol-induced hydrogen peroxide. Mutagenesis. 2011;26:489–98.CrossRefPubMed
37.
Zurück zum Zitat Hazawa M, Takahashi K, Sugata S, Kashiwakura I. (-)-epigallocatechin-3-o-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kda laminin receptor. J Nat Prod. 2011;74:695–700.CrossRefPubMed Hazawa M, Takahashi K, Sugata S, Kashiwakura I. (-)-epigallocatechin-3-o-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kda laminin receptor. J Nat Prod. 2011;74:695–700.CrossRefPubMed
38.
Zurück zum Zitat Fan LP, Shen JZ, Fu HY, Zhou HR, Shen SF, Yu AF. Effect of epigallocatechin-3-galate on human acute monocytic leukemia cell line u937 and its relevant mechanism. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010;18:286–90.PubMed Fan LP, Shen JZ, Fu HY, Zhou HR, Shen SF, Yu AF. Effect of epigallocatechin-3-galate on human acute monocytic leukemia cell line u937 and its relevant mechanism. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010;18:286–90.PubMed
Metadaten
Titel
Tea consumption and leukemia risk: a meta-analysis
verfasst von
Shanliang Zhong
Zhiyuan Chen
Xinnian Yu
Weixian Chen
Mengmeng Lv
Tengfei Ma
Jianhua Zhao
Publikationsdatum
01.06.2014
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 6/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-1675-9

Weitere Artikel der Ausgabe 6/2014

Tumor Biology 6/2014 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.